Related News
- Market trends, presidential debate, bank dividends: Asking for a Trend Friday was another big day on Wall Street, with major indexes (^DJI,^GSPC, ^IXIC) closing slightly lower for the day. One of the big topics of discussion was the presidential debate. President Joe Biden's poor performance has some Democrats calling for him to drop out of the race, Axios national political correspondent Alex Thompson talks about what's next for Biden and why First Lady Jill Biden plays a pivotal role. A number of big banks, including JPMorgan Chase (JPM), Citigroup (C), Wells Fargo (WFC), and Bank of America (BAC) announced they will raise their dividends after passing the Federal Reserve's bank stress test. The 2024 Summer Olympics are right around the corner. Arctic Wolf CEO and president Nick Schneider shares his insight into the preparations being made to prevent cyberattacks from impacting the games. For more expert insight and the latest market action, click here.
Yahoo Finance Video • 9 hours ago
^GSPC BAC JPM -
- JPMorgan, Citi, BofA, Wells Fargo all boost dividends Some of the biggest banks in the United States announced plans to increase their dividends after passing the latest Federal Reserve stress test. JPMorgan Chase (JPM) is raising its dividend to $1.25 per share from $1.15. The bank's board also authorized a $30 billion share repurchase plan. Bank of America (BAC) is boosting its dividend to $0.26/share from $0.24, Citigroup's (C) dividend is going to $0.56/share from $0.53, and Wells Fargo's (WFC) dividend rises to $0.40 from $0.35. Yahoo Finance anchor Julie Hyman breaks down the numbers in the video above. For more expert insight and the latest market action, click here to watch this full episode of Asking for a Trend. This post was written by Stephanie Mikulich.
Yahoo Finance Video • 10 hours ago
WFC C JPM - How Medicare drug price negotiations could hit pharma stocks As a string of negative headlines and promising new developments present ideal buying opportunities for investors, Josh Lipton and Julie Hyman perform a mid-year check on the pharmaceutical industry. Goldman Sachs senior biotechnology analyst Chris Shibutani joins Market Domination to break down the health of the pharmaceutical large-caps and unrecognized areas of opportunity in the sector. Shibutani says the industry is "quite healthy," but acknowledges there are always "cross currents." He points to "tremendous advancements" in biotechnology innovation rising to daunting unmet needs, from cancer to cardiovascular disease. The analyst points to "holy grail-like" opportunities such as obesity drugs, and notes improvements in chemotherapy and next-generation antibody-drug conjugates for cancer treatment. However, Shibutani explains that the Inflation Reduction Act may challenge the industry, as the landmark legislation stipulates drug price negotiation for Medicare that is "beginning to play out." For more expert insight and the latest market action, clickhereto watch this full episode of Market Domination. This article was written by Gabriel Roy
Yahoo Finance Video • 11 hours ago
LLY MRK ABBV - Walgreens plots bold comeback strategy, but the results will take time Walgreens CEO Tim Wentworth is reversing his predecessors' course to focus more on retail pharmacy needs in communities compared to a more vertically integrated healthcare strategy.
Yahoo Finance • 13 hours ago
CI WBA UNH - Why Russell reconstitution will focus on healthcare, tech sectors The Russell (^RUT) indexes are set for their annual reconstitution, scheduled to take place after Friday's closing bell. Indrani De, FTSE Russell's head of global investment research, joins Catalysts to provide insights into this event. De emphasizes that the reconstitution is "one of the biggest trading days of the year." She highlights the importance of indexes, describing them as "a representation of the market" and explaining that the reconstitution "captures the underlying changes in the economy." Highlighting current market trends, De points out that substantial technological and healthcare innovation is driving considerable growth. These areas will be a primary focus of the reconstitution process. "It's a very transparent process," De assures Yahoo Finance, adding, "It's simply going to reflect what's happening in the real economy." For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Angel Smith
Yahoo Finance Video • 16 hours ago
-
- Apple iPhone shipments jump 40% in China: Rpt Apple's (AAPL) iPhone shipments in China are growing, with a 40% year-over-year increase recorded in May, according to reports. This growth comes as the tech giant intensifies its discounting efforts to capture a larger Chinese market share. Yahoo Finance's Seana Smith and Brad Smith break down the details, providing insights into other international markets where Apple is looking to grow. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith
Yahoo Finance Video • 17 hours ago
AAPL - Stock market today: AI frenzy leads stocks to rip-roaring first half of 2024 Investors are watching for a cooling in the Fed-favored PCE print to boost rate-cut hopes as they assess Biden's faltering performance in the Trump debate.
Yahoo Finance • 18 hours ago
^IXIC ^DJI ^GSPC - Fed's preferred inflation gauge shows prices rose at slowest pace since March 2021 The May PCE report is the latest update on inflation as investors ponder when the Federal Reserve will cut interest rates.
Yahoo Finance • 19 hours ago
^GSPC ^IXIC ^DJI - Want $1,000 in Dividend Income? Here's How Much You Have to Invest in McDonald's Stock. Dividend investors have been loving McDonald's dividend for decades.
Motley Fool • 12 minutes ago
MCD ^GSPC -
- Forget Costco: These Unstoppable Stocks Are Better Buys These companies offer more value than Costco and could deliver bigger gains in the coming years.
Motley Fool • 20 minutes ago
COST AMZN AAPL - Artificial Intelligence (AI) Stocks Fueled Market Gains in the First Half. Is the Best Yet to Come? Nvidia and Super Micro Computer led the movement, soaring in the triple digits.
Motley Fool • 22 minutes ago
NVDA ^GSPC META - Is Nvidia Stock Actually Undervalued? Valuation, like beauty, is in the eyes of the beholder.
Motley Fool • 44 minutes ago
NVDA ^GSPC - Apple Watch Is Becoming Doctors’ Favorite Medical Device Doctors are using the Apple Watch as part of how they diagnose and help their patients manage disease—whether or not it’s been specifically approved for such applications by the Food and Drug Administration or other regulatory bodies. My own mother, who has a history of atrial fibrillation, a heart-rhythm disorder, is one such patient. The Apple Watch SE she bought on her doctor’s advice has been, by her account, a lifesaving intervention.
The Wall Street Journal • 4 hours ago
AAPL -
- Dow Jones Futures: Market Gives Mixed Signals, But This Remains; Tesla, Amazon In Buy Zones Despite some mixed signals, the market's power trend is intact. Tesla and Amazon broke out, leading stocks in buy zones.
Investor's Business Daily • 7 hours ago
TSLA ^GSPC COMP - Did Your Heart Just Skip a Beat? Your Watch Already Knows That and More. Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn’t worry.
Barrons.com • 8 hours ago
IRTC AAPL GOOG - Bank of America, JPMorgan, Goldman Raise Investor Payouts Post-Stress Tests Here is a rundown of some of the Friday announcements from U.S. banks that were subject to this week’s stress tests.
Barrons.com • 8 hours ago
C GSC WFC -
Barrons.com • 8 hours ago
^GSPC CBOE -
- Harbor Capital Appreciation Fund's Strategic Moves in Q2 2024: Spotlight on UnitedHealth Group Inc Insightful Portfolio Adjustments Reflect a Focused Investment Strategy
GuruFocus.com • 9 hours ago
UNH GOOG AVGO - Cassava Sciences Shares Plunge on Indictment Against Former Advisor A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
Barrons.com • 9 hours ago
SAVAW - If You'd Invested $1,000 in Apple Stock 27 Years Ago, Here's How Much You'd Have Today Steve Jobs' return to Apple in 1997 led to one of the most remarkable stock growth stories in history.
Motley Fool • 9 hours ago
AAPL MSFT
Performance Overview
Trailing total returns as of 6/28/2024, which may include dividends or other distributions. Benchmark is S&P 500
| Return | GNCP | S&P 500 |
|---|---|---|
| YTD | -90.00% | +14.48% |
| 1-Year | -99.00% | +24.71% |
| 3-Year | -99.80% | +27.56% |
